HOME › DRUGS › BELIMUMAB
ACTIVE SUBSTANCE / INN

BELIMUMAB

Brand name(s): BENLYSTA, Benlysta
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125370
Lupus Erythematosus, Systemic
ACTIVE SUBSTANCE
Belimumab
REGULATORS
FDA · EMA
SPONSORS / MAH
HUMAN GENOME SCIENCES INC., GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BENLYSTABLA125370HUMAN GENOME SCIENCES INC.Prescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BenlystaGlaxoSmithKline Trading Services LimitedAuthorised13/07/2011Lupus Erythematosus, Systemic

FULL INTELLIGENCE ON BELIMUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →